iThe current values are delayed, open demat account for live values.
Nifty Pharma
Nifty Pharma Performance
-
Open
23,338.70
-
High
23,418.20
-
Low
22,984.60
-
Prev Close
23,228.55
-
Dividend Yeild
0.58%
-
P/E
36.75
Nifty Pharma Chart
Stocks Performance
Color code for Stocks Performance
- 5% and above
- 5% to 2%
- 2% to 0.5%
- 0.5% to -0.5%
- -0.5% to -2%
- -2% to -5%
- -5% and below
Constituent Companies
| Company | Market Cap | Market Price | Volume | Sector |
|---|---|---|---|---|
| Abbott India Ltd | ₹63636 Cr |
₹29575
(1.37%)
|
10063 | Pharmaceuticals |
| Cipla Ltd | ₹120964 Cr |
₹1492.55
(0.87%)
|
2362974 | Pharmaceuticals |
| J B Chemicals & Pharmaceuticals Ltd | ₹29487 Cr |
₹1880.3
(0.64%)
|
193060 | Pharmaceuticals |
| Dr Reddys Laboratories Ltd | ₹112710 Cr |
₹1374
(0.59%)
|
1773057 | Pharmaceuticals |
| Lupin Ltd | ₹107564 Cr |
₹2248.9
(0.34%)
|
1022104 | Pharmaceuticals |
Nifty Pharma Sector Performance
Top Performing
| Sector Name | Percentage Change |
|---|---|
| Computer Education | 1.54 |
| Refineries | 0.52 |
| Printing & Stationery | 0.08 |
| Bearings | 0.11 |
Under Performing
| Sector Name | Percentage Change |
|---|---|
| Diamond, Gems and Jewellery | -2.88 |
| IT - Hardware | -0.98 |
| Leather | -1.33 |
| Ceramic Products | -1.48 |
NIFTY Pharma
The pharma industry’s performance is depicted in the NIFTY Pharma Index. 20 NSE-listed companies are included in the Index (NSE).
The level of the NIFTY Pharma Index shows the overall free float market valuation of all the companies included in the benchmark with a specific base market cap value. This index is calculated by using the free float market capitalization approach.
The NIFTY Pharma Index is utilized for several things, including creating structured products, ETFs, and index funds, as well as benchmarking investment portfolios.
The index was introduced in July 2005, with a reference level of 1000 and a baseline date of January 1st, 2001. The index is recalibrated every two years.
NIFTY Pharma Scrip Selection Criteria
● The companies under evaluation must be NIFTY 500 members.
● A shortfall amount of stocks will be chosen from the world of securities classified within the leading 800, predicated both on total daily turnover and daily total full market capitalization.
● Businesses must be engaged with the pharmaceutical industry.
● The company’s investing velocity in the previous six months must have been at least 90%.
● The company must have a six-month listing record. If a firm launches an IPO and meets the standard qualifying conditions for the index for a 3-month term rather than a period of 6 months, it will become qualified for inclusion within the index.
● Depending on the companies’ free-float market capitalization, the final 20 companies will be chosen.
● When making the final decision, priority will be given to firms that can be traded in the futures and options part of the NSE.
Other Indices
| Indices Name | Price | Price Change (% change) |
|---|---|---|
| India VIX | 14.5675 | -0.09 (-0.63%) |
| Nifty 10 Yr Benchmark G-Sec | 2452.3 | -0.81 (-0.03%) |
| Nifty 10 Yr Benchmark G-Sec (Clean Price) | 891 | -0.46 (-0.05%) |
| Nifty 100 | 24282.7 | -195.4 (-0.8%) |
| Nifty 100 Alpha 30 Index | 18082.85 | 0 (0%) |
Faqs
Which is the current best pharma company in India?
Cipla, Alkem, Sun Pharma, Torrent Pharma, and Dr. Reddy’s Laboratories are the current best pharma-based companies in India in terms of market capitalization.
How do I calculate NIFTY Pharma?
Each stock’s weightage in the index is determined according to its free-float market capitalization, except for the top three stocks, whose combined weight cannot exceed 62% at the point of rebalancing, and no separate stock should have a weightage greater than 33%. Index Rebalancing: The index is recalibrated every two years.
How many companies are available in the NIFTY 50 index?
The Nifty 50 Index comprises a total of 4 businesses from the Nifty Pharma Index. These companies are Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Divi’s Laboratories Ltd., and Sun Pharmaceuticals Ltd.
Is it risky to invest in pharma stocks?
Buying stocks of pharmaceutical companies can sometimes be risky due to the high costs and lengthy time between pharmaceutical research and approval (considering that the drug research procedure is successful and regulatory permission is given).
Should I start investing in pharmaceutical stocks?
Despite the instability, pharma businesses might be appealing to long-term traders. Traders can earn higher returns when they purchase at the correct time because the pharmaceutical industry is growing rapidly and has become increasingly important to daily life.
What is the cause behind the impulsive growth of the pharma sector?
Several pharma companies have experienced a spike in revenue due to authorities in the USA and other nations approving immunizations against the COVID-19 virus. The need for pharmaceutical stocks is rising; therefore, now is an excellent time to buy them.
What are the few major uses of NIFTY Pharma?
There are several uses of NIFTY Pharma in real-time. Still, the few major ones include the creation and implementation of structured products, index funds, ETFs, and benchmarking or evaluating mutual funds portfolios.
Latest News
- Jan 08, 2025
US Job Openings Defy Expectations US job openings unexpectedly rose to 8.1 million in November, up from 7.8 million in October, according to the Labor Department's latest report. Although this figure has declined from 8.9 million a year ago and the March 2022 peak of 12.2 million, it still remains higher than pre-pandemic levels.
- Jan 08, 2025
NTPC Green Energy Ltd., the clean energy subsidiary of NTPC Ltd., India's largest thermal power producer, is set to embark on an ambitious green hydrogen hub project in Pudimadaka, Andhra Pradesh. With an estimated cost of $21 billion (Rs 1.8 trillion), this development marks a significant milestone in India's National Green Hydrogen Mission.
- Jan 08, 2025
Leo Dry Fruits & Spices Trading Limited, a specialized manufacturer and trader of spices and dry fruits operating since 2019, marked a strong entry into the public markets on Wednesday, 8th January 2025. The company, which has established itself with popular brands like VANDU and FRYD across B2B, B2C, and D2C channels, commenced trading on the BSE SME platform amid significant investor enthusiasm.
- Jan 08, 2025
The National Stock Exchange of India (NSE) has announced the inclusion of six new securities in the Futures and Options (F&O) segment, effective from January 31, 2025. The stocks being added are Castrol India, Gland Pharma, NBCC, Phoenix, Solar Industries India, and Torrent Power.
Latest Blogs
Nifty Prediction for Today - 8 January 2025 NIFTY recovered some lost ground and closed 0.39% up. ONGC was the top performer on a broker upgrade amidst expectations of production ramp up. SBILIFE, HDFCLIFE, TATAMOTORS and ADANIENT were among the stocks that bounced back strongly. On the other hand, IT services stocks performed poorly. ADR was healthy at 2, reflecting a broad-based participation.
- Jan 08, 2025
Thе Indian train nеtwork is onе of thе biggеst in thе world, and thе railway businеss plays an intеgral part in thе country's еconomy. With thе govеrnmеnt's focus on infrastructurе dеvеlopmеnt and improving thе train systеm, buying thе bеst railway stocks in India can bе a rеwarding chancе for invеstors. In this article, we will study thе bеst train stocks in India and provide insights into thе industry's succеss and growth possibilitiеs.
- Jan 07, 2025
Nifty Prediction for Today - 7 January 2025 On HMPV jitters, concerns over slowing earnings momentum and a weak INR, all major indices corrected heavily. NIFTY closed down 1.6%. Healthcare and IT bucked the trend while most capex related names fell sharply. Needless to say, ADR (Advance Decline Ratio) was extremely bad with only 7 stocks being in the green zone.
- Jan 07, 2025
